Samuel Gurrion Ouma

机构：Kampala University · ORCID：0000-0003-3559-9028

发表论文 35 篇 · 总被引 1049 次 · h-index 13

代表论文

• Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial (2022 · The Lancet · 被引 584)
• Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials (2023 · JAMA Network Open · 被引 38)
• Risk-stratified treatment for drug-susceptible pulmonary tuberculosis (2024 · Nature Communications · 被引 34)
• Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial (2023 · The Lancet Respiratory Medicine · 被引 25)
• Schistosoma mansoni Infection Is Associated With a Higher Probability of Tuberculosis Disease in HIV-Infected Adults in Kenya (2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 21)
• Activation-Induced Marker Expression Identifies Mycobacterium tuberculosis–Specific CD4 T Cells in a Cytokine-Independent Manner in HIV-Infected Individuals with Latent Tuberculosis (2020 · ImmunoHorizons · 被引 20)